Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Estella Matutes, L. Bonomini et al.|Blood|2021Cited by 96
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyB. Gerber, Guido Ghilardi, Thomas Pabst et al.|Bone Marrow Transplantation|2018Cited by 20
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandAlden A. Moccia, Felicitas Hitz, Stefanie Aeppli et al.|Hematological Oncology|2020Cited by 15
GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMAFerdinando Bonfiglio, Michele Merli, Alessio Bruscaggin et al.|Hematological Oncology|2021Cited by 13